Eight Roads portfolio company J-Pharma listed on the Tokyo Stock Exchange Growth market in March 2026.
J-Pharma is a clinical stage biopharmaceutical company focused on developing novel pharmaceuticals to address unmet medical needs, particularly in the area of advanced cancers and autoimmune diseases
J-Pharma is a clinical stage biopharmaceutical company focused on developing novel pharmaceuticals to address unmet medical needs, particularly in the area of advanced cancers and autoimmune diseases.